Abstract
Compelling evidence suggests that up to 15% of PC may be due to germline Pathogenic Variants (PV) in high-risk genes. Because of this, international guidelines recommend multigene germline testing for all PC patients. However, the precise contribution of additional susceptibility genes other than BRCA is still to be clarified, as different panel were used among different studies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
